Sunmax Biotechnology Co Ltd (4728) — Free Cash Flow Generation Index
Sunmax Biotechnology Co Ltd (4728) has a Free Cash Flow Generation Index of 0.89x as of September 2025. Free cash flow of NT$143.40 Million represents 1% of operating cash flow (NT$160.84 Million). Explore Sunmax Biotechnology Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sunmax Biotechnology Co Ltd Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Sunmax Biotechnology Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 4728 cash generation efficiency.
Annual Free Cash Flow Generation for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year Free Cash Flow Generation Index for Sunmax Biotechnology Co Ltd. Check how aggressively does Sunmax Biotechnology Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | NT$360.75 Million | NT$397.37 Million | NT$36.61 Million | ▲ +4.4% |
| 2023 | 0.87x | NT$738.16 Million | NT$848.56 Million | NT$110.39 Million | ▲ +56.3% |
| 2022 | 0.56x | NT$190.94 Million | NT$342.97 Million | NT$152.03 Million | ▲ +1215.2% |
| 2021 | -0.05x | NT$-12.14 Million | NT$243.28 Million | NT$255.43 Million | ▼ -107.5% |
| 2020 | 0.66x | NT$256.88 Million | NT$386.97 Million | NT$130.10 Million | ▼ -29.0% |
| 2019 | 0.94x | NT$270.70 Million | NT$289.51 Million | NT$13.68 Million | ▼ -1.8% |
| 2018 | 0.95x | NT$96.00 Million | NT$100.83 Million | NT$4.72 Million | ▲ +5.6% |
| 2017 | 0.90x | NT$33.44 Million | NT$37.09 Million | NT$3.15 Million | ▼ -29.9% |
| 2016 | 1.29x | NT$21.31 Million | NT$16.58 Million | NT$4.73 Million | — |